Roger Drew
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
Papers in ⓘ
-
- Glutathione Transferases and Polymorphisms 5
- Glycosylation and Glycoproteins Research 4
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 7
- Drug-Induced Hepatotoxicity and Protection 5
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- John O. Miners (6 shared papers)A.R. Bradwell (4 shared papers)Mark T. Drayson (2 shared papers)Graham P. Mead (2 shared papers)Lian X. Tang (2 shared papers)Hugh D Carr-Smith (2 shared papers)Brian G. Priestly (5 shared papers)Donald Birkett (2 shared papers)
- Journals
- Biochemical Pharmacology (7 papers)Toxicology and Applied Pharmacology (6 papers)Pharmacology (2 papers)Toxicology (2 papers)Clinical and Experimental Pharmacology and Physiology (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Roger Drew
46 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 109
- Hematology 479
- Pharmacology 337
- Oncology 595
- Genetics 187
- Biochemistry 113
Countries citing papers authored by Roger Drew
This map shows the geographic impact of Roger Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Drew more than expected).
Fields of papers citing papers by Roger Drew
This network shows the impact of papers produced by Roger Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Drew. The network helps show where Roger Drew may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Drew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 452 | |
| 2 | A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. | 2001 | 299 |
| 3 | 2001 | 264 | |
| 4 | 1984 | 238 | |
| 5 | 1984 | 116 | |
| 6 | 1984 | 62 | |
| 7 | Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains. | 1981 | 61 |
| 8 | 1979 | 58 | |
| 9 | 1975 | 52 | |
| 10 | 1979 | 49 | |
| 11 | 1988 | 47 | |
| 12 | 1988 | 30 | |
| 13 | Effect of whole-body hyperthermia on the disposition and metabolism of adriamycin in rabbits. | 1978 | 30 |
| 14 | 1980 | 23 | |
| 15 | 1973 | 22 | |
| 16 | 1976 | 19 | |
| 17 | 1987 | 17 | |
| 18 | 1977 | 17 | |
| 19 | 1996 | 16 | |
| 20 | 1992 | 15 |
About Roger Drew
Roger Drew is a scholar working on Molecular Biology, Pharmacology, Oncology, Pharmacology and Surgery, having authored 47 papers that have together received 2.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacogenetics and Drug Metabolism (7 papers), Drug-Induced Hepatotoxicity and Protection (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Glutathione Transferases and Polymorphisms (5 papers), Metabolism and Genetic Disorders (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Hematology (479 citations), Pharmacology (337 citations), Oncology (595 citations), Genetics (187 citations) and Biochemistry (113 citations). Roger Drew has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include John O. Miners, A.R. Bradwell, Mark T. Drayson, Graham P. Mead, Lian X. Tang, Hugh D Carr-Smith, Brian G. Priestly, Donald Birkett, Theodore E. Gram and Zahid H. Siddik. Their work appears in journals such as Biochemical Pharmacology, Toxicology and Applied Pharmacology, Pharmacology, Toxicology and Clinical and Experimental Pharmacology and Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.